Search
(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime
go.drugbank.com/drugs/DB08553ExperimentalThis compound belongs to the phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide
go.drugbank.com/drugs/DB06945ExperimentalN-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide is a solid. This compound belongs to the diarylethers. … This substance is known to target a disintegrin and metalloproteinase with thrombospondin motifs 5.
Synonyms: N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamideLomedeucitinib
go.drugbank.com/drugs/DB21649InvestigationalLomedeucitinib is under investigation in clinical trial NCT05730725 (A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis).
Dimethyltryptamine
go.drugbank.com/drugs/DB01488IllicitInvestigationalAn N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine.
Synonyms: N,N-dimethyltryptamine, N,N-dimethyl-1H-indole-3-ethylamineCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeGemopatrilat
go.drugbank.com/drugs/DB20954ExperimentalGemopatrilat is a small molecule drug. Gemopatrilat has a monoisotopic molecular weight of 378.16 Da.
Categories: Agents Acting on the Renin-Angiotensin SystemCadralazine
go.drugbank.com/drugs/DB13452ExperimentalCategories: Arteriolar Smooth Muscle, Agents Acting OnTetulomab tetraxetan Lu-177
go.drugbank.com/drugs/DB12227InvestigationalBetalutin has been used in trials studying the treatment of Non-Hodgkin Lymphoma and Relapsed, Diffuse Large B-cell Lymphoma.
GI-181771X
go.drugbank.com/drugs/DB12309ExperimentalGski181771 X is under investigation in clinical trial NCT00600743 (Effect of a CCK-1R Agonist on Food Intake in Humans).
SGI-1776
go.drugbank.com/drugs/DB12494InvestigationalSGI-1776 has been used in trials studying the treatment of Prostate Cancer, Non-Hodgkins Lymphoma, and Relapsed/Refractory Leukemias.